You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Medications Videos on Diabetes Health TV
Close Encounter - A Profile of a Diabetes Patient and Business Insider
Todd speaks about Levemir
New Small Molecule Drugs for Type 2 - Human Trials Underway
Popular Symlin Articles
Highly Recommended Symlin Articles
The following letter to the editor asks Diabetes Health subscribers to share their experiences with Symlin. If you use Symlin, please tell us about it in the “Comments” section. Have you had more success in managing your diabetes with Symlin? How has your insurance company treated you regarding your prescription cost?
7 comments - Sep 27, 2012 -
Amylin Pharmaceuticals has announced that it will collaborate with the Juvenile Diabetes Research Foundation to test a combination of Symlin and insulin in injectible form as a type 1 therapy.
0 comments - Jun 3, 2011 -
Insulin has a companion, and it's called amylin. Amylin is a small hormone that is released along with insulin by the beta cells of the pancreas in response to a meal. When people are insulin-deficient, they are amylin-deficient as well. Amylin wasn't even discovered until 1970, and it was not until the 1990s that scientists began to figure out what amylin does. But they now know that it partners with insulin to help control blood sugar levels, each in its own way:
1 comment - Jan 28, 2011 -
The Food and Drug Administration (FDA) just approved pre-filled pens for administering Symlin, which was previously available only in vials. The SymlinPen 60 delivers 15, 30, 45, or 60 micrograms per dose.
9 comments - Nov 14, 2007 -
Symlin, or pramlintide, is synthetic amylin, a natural hormone that slows stomach emptying and leads to a feeling of fullness. Currently Symlin is used to dampen blood sugar rises in people with diabetes, but it's showing potential as a weight loss drug as well, according to a recent study.
1 comment - Oct 12, 2007 -
As many of us know to our dismay, the desire to chow down fatty, sugary food can be very strong indeed. In a recent six-week study of 88 obese, non-diabetic men and women, Symlin, a synthetic hormone currently used to dampen diabetic blood sugar swings, was found to dampen those very desires.
1 comment - Jun 27, 2007 -
I recently had the privilege of interviewing Ginger Graham, the CEO who led Amylin during the launch of its two first-in-class medicines, Byetta and Symlin. A fascinating woman with a very personal leadership style, she had the following to say about her past achievements and her future hopes.
0 comments - Jun 2, 2007 -
On March 16, 2005, Amylin Pharmaceuticals, Inc., of San Diego, California, announced it had received FDA approval for Symlin (pramlintide acetate) injections to be used in conjunction with insulin to treat diabetes.
0 comments - Jun 1, 2005 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.